Structure (Chl0d 0000 01)
Chlorpromazine Hydrochloride Injection
Product Images NDC 65219-128
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 65219-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Company Logo (Chl0d 0000 02)
Package Label – Principal Display – Shelf Carton (Chl0d 0000 03)
This text appears to be a label or packaging information for an injection medication called "Chlorpromazine HCl Injection, USP" with a concentration of 25 mg per mL. The text provides directions for use, storage instructions, composition details, dosage information, and manufacturer details. The medication is intended for deep intramuscular use and is packaged in 1mL single-dose vials. It contains Chlorpromazine hydrochloride, ascorbic acid, sodium metabisulfite, sodium sulfite, and sodium chloride in a solution for injection. The text advises protecting the medication from light and freezing, and storing it at a temperature between 20°C to 25°C (68°F to 77°F). Detailed prescribing information can be found in the package insert.*
Package Label – Principal Display – Vial Label (Chl0d 0000 04)
This text provides information about Chlorpromazine HCI Injection, USP manufactured for Fresenius Kabi in India. It includes details about discarding unused portions of the product and bears a product code "LAIA-177.00".*
Package Label – Principal Display – Shelf Carton (Chl0d 0000 05)
The text appears to be a description of a medication labeled as "chlorpromazine HCI Injection, USP" intended for deep intramuscular use. The medication is available in 25 mg per mL concentration, and each single-dose vial contains 2 mL. The formulation includes chlorpromazine hydrochloride, ascorbic acid, sodium metabisulfite, sodium sulfite, and sodium chloride in water for injection. The recommended storage conditions are at 20° to 25°C with protection from light, and unused portions should be discarded. It is important to refer to the package insert for complete prescribing information.*
Package Label – Principal Display – Vial Label (Chl0d 0000 06)
This text pertains to Chlorpromazine Hydrochloride Injection, USP. It includes information regarding the manufacturer, which is Fresenius Kabi based in Lake Zurich, IL 60047, and indicates that the product is made in India. It also includes a reference code number of HP/Drugs/MB/13/859. Additionally, there is a statement advising to discard any unused portion of the product. The text may also contain a reference number, 404000, and a code LAIA-178.00.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
